Identification of 11β-HSD1 inhibitors through enhanced sampling methods

Area of Science:

• Biochemistry
• Computational Chemistry
• Pharmacology

Background:

• 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) is a key enzyme in metabolic regulation.
• Developing potent and selective 11β-HSD1 inhibitors is crucial for treating metabolic disorders.
• Aminoarylbenzosuberene (AAB) derivatives represent a potential class of novel inhibitors.

Purpose of the Study:

• To computationally screen and evaluate aminoarylbenzosuberene (AAB) molecules as potential inhibitors of 11β-HSD1.
• To identify specific AAB molecules with enhanced binding affinity and interactions with the 11β-HSD1 protein.

Main Methods:

• In silico analysis of AAB molecules.
• Molecular dynamics simulations, including conventional, steered, and enhanced umbrella sampling.
• Comparative analysis of binding affinity against standard co-crystallized inhibitors.

Main Results:

• The AAB4 molecule exhibited significantly stronger interactions and binding affinity with the 11β-HSD1 protein compared to standard inhibitors.
• Computational simulations provided detailed insights into the binding mechanisms of AAB molecules.

Conclusions:

• Aminoarylbenzosuberene (AAB) molecules, particularly AAB4, show promise as effective 11β-HSD1 inhibitors.
• In silico methods are valuable for the rational design of novel enzyme inhibitors.